|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
509 Madison Avenue - Suite 306,New York,NY,US
|
|
Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.
Further information about Tonix can be found at www.tonixpharma.com.
|
Tonix Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Tonix Pharmaceuticals email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Tonix Pharmaceuticals customer service number in your country click here to find.
Mikaela Fox is the CEO of Tonix Pharmaceuticals. To contact Mikaela Fox email at [email protected]. Or you may call +1.7742251003
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.